ScoreWhy is Krebs Biochemicals & Industries Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -11.65% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
The company has declared Negative results for the last 4 consecutive quarters
- PAT(9M) At Rs -19.73 cr has Grown at -58.24%
- NET SALES(Latest six months) At Rs 9.65 cr has Grown at -62.52%
- DEBTORS TURNOVER RATIO(HY) Lowest at 19.44 times
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -38.96%, its profits have fallen by -26.2%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Krebs Biochem for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Krebs Biochem
-28.59%
-0.68
57.28%
Sensex
4.25%
0.36
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.65%
EBIT Growth (5y)
-0.75%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.39
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.50%
ROCE (avg)
-33.39%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
-0.87
EV to EBIT
-16.60
EV to EBITDA
-23.81
EV to Capital Employed
5.80
EV to Sales
13.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-34.92%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NO KEY POSITIVE TRIGGERS
-11What is not working for the Company
PAT(9M)
At Rs -19.73 cr has Grown at -58.24%
NET SALES(Latest six months)
At Rs 9.65 cr has Grown at -62.52%
DEBTORS TURNOVER RATIO(HY)
Lowest at 19.44 times
Loading Valuation Snapshot...
Here's what is not working for Krebs Biochem
Net Sales - Latest six months
At Rs 9.65 cr has Grown at -62.52%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Nine Monthly
At Rs -19.73 cr has Grown at -58.24%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 19.44 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
